Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 5OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Lung Neoplasms 6Mesothelioma, Malignant 3Uterine Cervical Neoplasms 2Mesothelioma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Ovarian Neoplasms 1Gestational Trophoblastic Disease 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Ovarian Epithelial 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 8Doxorubicin 7Cisplatin 7Radiotherapy 4Filgrastim 4Chemotherapy, Adjuvant 3Tamoxifen 2Radiotherapy, Intensity-Modulated 2Observation 2Medroxyprogesterone 2Letrozole 2Ifosfamide 2Gene Expression Profiling 2Carboplatin 2Amifostine 2ridaforolimus 1perifosine 1lenvatinib 1irofulven 1abemaciclib 1X-Rays 1Trabectedin 1Therapeutics 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Adjuvant 1Polymerase Chain Reaction 1Phantoms, Imaging 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Endometrial Neoplasms × Pemetrexed × Clear all
NCT00087100 2014-02-14

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer

GOG Foundation

Phase 2 Completed
51 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡